Display search results for ** instead (3 products)

3 Item(s)

24 Jul 2020  |  North America

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies,...

USD 4,950.00
09 Jul 2020  |  North America

Post-pandemic Global Healthcare Market Outlook, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’

Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...

USD 4,950.00
02 Oct 2020  |  Global

Biosimilar Access to Newer Therapy Areas such as Ophthalmology to drive major growth of Biosimilar Market, 2020-2026

Outsourced manufacturing of complex third wave of biosimilars to spark new growth opportunities

The Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry highlighting the key growth opportunities, market revenue forecast and trends that will influence the industry with the third wave biosimilars. The global third wave biosimilars market covered in this study includes 2 major segments ...

USD 4,950.00

USD 4,455.00 save 10 %

3 Item(s)